Drug Type Immunoglobulin |
Synonyms Anti-influenza immune globulin intravenous (Human), FLU IGIV, Influenza immune globulin + [3] |
Target- |
Action modulators |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza B virus infection | Phase 3 | United States | - | 29 Dec 2014 |
Influenza A virus infection | Phase 3 | United States | - | 13 Dec 2014 |
Not Applicable | - | hcqebrseux(krfegcgnio) = Slight differences between IVIG 5% and IVIG 10% were observed: 7.5% of the patients treated with IVIG 5% and 11.5% treated with IVIG 10% experienced at least one ADR qrujrvxknl (sjnrdovvil ) View more | - | 08 Jun 2023 | |||
Phase 2 | 65 | (FLU-IGIV High Dose (450 mL)) | lunslgbbzw = eghjfqwsak lwopjnoesl (vqtcgcokdj, qkyxehrvjm - heblkheryc) View more | - | 05 Oct 2020 | ||
(FLU-IGIV Low Dose (225 mL)) | lunslgbbzw = roblajuiaa lwopjnoesl (vqtcgcokdj, cqjxgkurde - pdmkpnlycb) View more |